title: Evaluation of a communication campaign to improve continuation among first-time injectable contraceptive users in Nyando District, Kenya.
abstract: BACKGROUND
  Communication campaigns might be a viable means of improving contraceptive continuation; however, few such interventions aimed at reducing contraceptive discontinuation have been evaluated.
  
  
  METHODS
  Data were collected from independent samples of new injectable users in Nyando District, Kenya-site of a communication campaign to increase contraceptive continuation-and in a comparison district, nine months before and nine months after intervention implementation. Survival analysis was used to compare the intervention and comparison groups with respect to the distribution of time until first discontinuation of modern method use among women still in need of family planning.
  
  
  RESULTS
  Exposure to family planning information was high in both the treatment and the comparison district before (97% and 85%, respectively) and after the intervention (99% and 78%). Postintervention, 5% of women in the comparison district discontinued by 98 days, 8% by 196 days and 23% by 294 days; the proportions in the treatment district were 4%, 6% and 16%, respectively. No significant difference between the districts was found in the ninemonth postintervention contraceptive continuation rates. Having method-related side effects or health concerns was the reason most consistently associated with discontinuation. Other factors associated with discontinuation differed between the districts.
  
  
  CONCLUSIONS
  Addressing method-related side effects and health concerns will be critical in improving continuation of the injectable.
authors: Scientist, FHI 360, Durham, NC, USA, hburke@fhi360.org.
authors: Holly
authors: H
authors: McClain Burke
authors: Constance
authors: C
authors: Ambasa-Shisanya
mesh_terms: D000328:Adult; D003142:Communication; D003268:Contraception Behavior / Q000523:psychology*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003906:Developing Countries; D005193:Family Planning Services / Q000458:organization & administration*; D005260:Female; D006293:Health Promotion / Q000458:organization & administration*; D006801:Humans; D007267:Injections; D007630:Kenya; D008402:Mass Media; D008962:Models, Theoretical; D010352:Patient Dropouts / Q000523:psychology / Q000706:statistics & numerical data; D015397:Program Evaluation
chemical_list: D003271:Contraceptive Agents, Female